TrialPanorama/TrialPanorama-database huggingface dataset:
Study 11376633 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 18294484 — Surrogate Endpoint (SUR): Serum creatinine
Study 8471696 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study 20435187 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study 20435187 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 16335887 — Surrogate Endpoint (SUR): Blood pressure
Study 11910308 — Surrogate Endpoint (SUR): Blood pressure
Study 20335831 — Predictive Biomarker (PRD): EVL mRNA
Genes: EVL; RNB6
Study 11990441 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 1991261 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 27290982 — Surrogate Endpoint (SUR): Blood pressure
Study 10188789 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study 29186759 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29186759 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 26159452 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 23864583 — Surrogate Endpoint (SUR): Blood pressure
Study 15262244 — Safety Biomarker (SAF): Hyaluronic acid
Study 8993254 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8993254 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 8993254 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 8993254 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8993254 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 8993254 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 25375979 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 8691512 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 7049708 — Surrogate Endpoint (SUR): Blood pressure
Study 7049708 — Surrogate Endpoint (SUR): Serum uric acid
Study 30413379 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30413379 — Surrogate Endpoint (SUR): Pathological complete response
Study 17460710 — Surrogate Endpoint (SUR): Blood pressure
Study 11583728 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 11583728 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 21700924 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 28708863 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28708863 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 28708863 — Predictive Biomarker (PRD): ENTPD1 mRNA
Genes: ENTPD1; CD39
Study 28708863 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 23922114 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 6731327 — Surrogate Endpoint (SUR): Blood pressure
Study 29187594 — Predictive Biomarker (PRD): SLC2A9 mRNA
Genes: SLC2A9; GLUT9
Study 29187594 — Predictive Biomarker (PRD): ABCG2 mRNA
Genes: ABCG2; ABCP; BCRP; BCRP1; MXR
Study 22527829 — Surrogate Endpoint (SUR): Serum creatinine
Study 16140974 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study 16140974 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 16140974 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 31956660 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31956660 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26975818 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26975818 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 26975818 — Predictive Biomarker (PRD): IL2
Genes: IL-2; TCGF
Study 26975818 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 26975818 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 26975818 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 26975818 — Safety Biomarker (SAF): IL-6 and IL-10
Study 17617283 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 17617283 — Surrogate Endpoint (SUR): Blood pressure
Study 17617283 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17617283 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 23365148 — Predictive Biomarker (PRD): SGCG mRNA
Genes: SGCG
Study 19127197 — Surrogate Endpoint (SUR): Blood pressure
Study 19127197 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29395424 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 9704200 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 20848538 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19194270 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19194270 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 19194270 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 19194270 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 19194270 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 17533020 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 17533020 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9741224 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 2647291 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 18486782 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 17000189 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 14558436 — Surrogate Endpoint (SUR): Blood pressure
Study 20107199 — Surrogate Endpoint (SUR): Blood pressure
Study 2521816 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 27299675 — Surrogate Endpoint (SUR): Serum creatinine
Study 25976063 — Surrogate Endpoint (SUR): Blood pressure
Study 31968400 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 27600055 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 8833557 — Surrogate Endpoint (SUR): Blood pressure
Study 8833557 — Surrogate Endpoint (SUR): Serum creatinine
Study 8833557 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 3886357 — Surrogate Endpoint (SUR): Blood pressure
Study 30137218 — Surrogate Endpoint (SUR): Blood pressure
Study 30137218 — Surrogate Endpoint (SUR): Forced vital capacity
Study 30137218 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 30137218 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30137218 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 17045796 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 14751652 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 14751652 — Surrogate Endpoint (SUR): Blood pressure
Study 9324165 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 12771323 — Monitoring Biomarker (MOI): Apolipoprotein A-IV
Genes: APOA4
Study 10470628 — Surrogate Endpoint (SUR): Blood pressure
Study 8544269 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 31379269 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 31379269 — Safety Biomarker (SAF): BDNF
Study 21586234 — Monitoring Biomarker (MOI): HBV DNA
Study 18363087 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 14581419 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 6547563 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 27950666 — Surrogate Endpoint (SUR): Pathological complete response
Study 14974922 — Surrogate Endpoint (SUR): Bone mineral density
Study 10826408 — Surrogate Endpoint (SUR): Blood pressure
Study 6149772 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study 18407386 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study 15764631 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 12365325 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 2644749 — Surrogate Endpoint (SUR): Blood pressure
Study 766574 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 15204248 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15204248 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 11579243 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11579243 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8250311 — Surrogate Endpoint (SUR): Blood pressure
Study 30511959 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study 30511959 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23522121 — Surrogate Endpoint (SUR): Blood pressure
Study 23522121 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25168918 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 9506325 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 28875327 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study 28390695 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 28390695 — Surrogate Endpoint (SUR): Blood pressure
Study 26301484 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 18499604 — Surrogate Endpoint (SUR): Blood pressure
Study 20876734 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 18284057 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 28853509 — Surrogate Endpoint (SUR): Blood pressure
Study 26378246 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study 17558730 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30935545 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 25990355 — Surrogate Endpoint (SUR): Bone mineral density
Study 18752430 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 15895329 — Predictive Biomarker (PRD): C6orf15 mRNA
Genes: C6orf15; STG; UNQ1840/PRO3566
Study 1697836 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 19207321 — Safety Biomarker (SAF): Hyaluronic acid
Study 17161821 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 17161821 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31640794 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 2157313 — Surrogate Endpoint (SUR): Blood pressure
Study 29513111 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27003645 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 21556746 — Surrogate Endpoint (SUR): Serum creatinine
Study 14601477 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 14601477 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 20686486 — Surrogate Endpoint (SUR): Blood pressure
Study 18939907 — Surrogate Endpoint (SUR): Blood pressure
Study 14515443 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 14515443 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 8879341 — Surrogate Endpoint (SUR): Blood pressure
Study 28912447 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 17699388 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15507176 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 8072077 — Surrogate Endpoint (SUR): Serum testosterone
Study 28002679 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 25887660 — Predictive Biomarker (PRD): ASPSCR1 mRNA
Genes: ASPSCR1; ASPL; RCC17; TUG; UBXD9; UBXN9
Study 8988823 — Surrogate Endpoint (SUR): Blood pressure
Study 31892574 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 31892574 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study 25736126 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 23263721 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 12487852 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 9793223 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 29668990 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study 22785552 — Surrogate Endpoint (SUR): Serum potassium
Study 10930484 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 23220798 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23220798 — Surrogate Endpoint (SUR): Blood pressure
Study 23220798 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16544177 — Surrogate Endpoint (SUR): Serum creatinine
Study 9185636 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9185636 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 2969912 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study 27525532 — Surrogate Endpoint (SUR): Serum calcium
Study 10353861 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10353861 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 29081179 — Predictive Biomarker (PRD): ILK mRNA
Genes: ILK; ILK1; ILK2
Study 29081179 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 23438054 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 24669841 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 12602460 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 26621261 — Predictive Biomarker (PRD): MMP28 mRNA
Genes: MMP28; MMP25; UNQ1893/PRO4339
Study 18082488 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17081360 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 12843739 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9219165 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 9219165 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 3118755 — Surrogate Endpoint (SUR): Blood pressure
Study 18653753 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study 10915748 — Monitoring Biomarker (MOI): HBV DNA
Study 15690408 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 121640 — Surrogate Endpoint (SUR): Blood pressure
Study 121640 — Surrogate Endpoint (SUR): Serum triglycerides
Study 23059865 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 23059865 — Surrogate Endpoint (SUR): Blood pressure
Study 12728082 — Surrogate Endpoint (SUR): Bone mineral density
Study 10918548 — Surrogate Endpoint (SUR): Blood pressure
Study 4050842 — Surrogate Endpoint (SUR): Blood pressure
Study 10413893 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 1900225 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 1900225 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 12011578 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19958860 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 19958860 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 12201939 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 8567768 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 15305335 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 29230665 — Predictive Biomarker (PRD): Hormone receptor
Study 24901386 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 18345398 — Surrogate Endpoint (SUR): Blood pressure
Study 16223944 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 30082326 — Surrogate Endpoint (SUR): Blood pressure
Study 24780614 — Surrogate Endpoint (SUR): Serum potassium
Study 3041785 — Predictive Biomarker (PRD): GPT mRNA
Genes: GPT; AAT1; GPT1
Study 20078940 — Surrogate Endpoint (SUR): Blood pressure
Study 16376092 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 23515006 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 11100393 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 29926979 — Surrogate Endpoint (SUR): Bone mineral density
Study 25362223 — Surrogate Endpoint (SUR): Serum potassium
Study 17852012 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 17852012 — Predictive Biomarker (PRD): ASPSCR1 mRNA
Genes: ASPSCR1; ASPL; RCC17; TUG; UBXD9; UBXN9
Study 17852012 — Surrogate Endpoint (SUR): Forced vital capacity
Study 11195609 — Surrogate Endpoint (SUR): Blood pressure
Study 25079374 — Predictive Biomarker (PRD): GSTZ1 mRNA
Genes: GSTZ1; MAAI
Study 30183102 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 7762525 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2405112 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 19068191 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 10201553 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 10201553 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 7867677 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 30783954 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-223
Genes: MIR223
Study 30783954 — Safety Biomarker (SAF): miR-15a
Genes: MIR15A
Study 10223244 — Predictive Biomarker (PRD): ANK1 mRNA
Genes: ANK1; ANK
Study 10223244 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 31439681 — Predictive Biomarker (PRD): ORMDL3 mRNA
Genes: ORMDL3
Study 22269279 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22269279 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22269279 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 12227646 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 12227646 — Surrogate Endpoint (SUR): Blood pressure
Study 12227646 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 23148243 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 21864626 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19707015 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28118369 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 23364255 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23364255 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 23364255 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 7515507 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 7515507 — Predictive Biomarker (PRD): POMC mRNA
Genes: POMC
Study 7515507 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study 31046423 — Surrogate Endpoint (SUR): Blood pressure
Study 17273659 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8555780 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 17923538 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 15516378 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 15516378 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 28440810 — Safety Biomarker (SAF): DRD2
Study 25693969 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 23527977 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 14747117 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 21185506 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 27600013 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11505405 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study 30629770 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 19887581 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 17699531 — Surrogate Endpoint (SUR): Blood pressure
Study 29231473 — Predictive Biomarker (PRD): TSPAN31 mRNA
Genes: TSPAN31; SAS
Study 29231473 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 15361700 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9301431 — Surrogate Endpoint (SUR): Blood pressure
Study 29020601 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 20455246 — Predictive Biomarker (PRD): PLXNA2 mRNA
Genes: PLXNA2; KIAA0463; OCT; PLXN2; UNQ209/PRO235
Study 18606032 — Predictive Biomarker (PRD): DRD4 mRNA
Genes: DRD4
Study 11918753 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11918753 — Surrogate Endpoint (SUR): Blood pressure
Study 1333098 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 30992293 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28515107 — Surrogate Endpoint (SUR): Serum calcium
Study 23945130 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 15310638 — Surrogate Endpoint (SUR): Blood pressure
Study 11318078 — Surrogate Endpoint (SUR): Blood pressure
Study 26599957 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 31221221 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31221221 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 31221221 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 25527767 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 25527767 — Predictive Biomarker (PRD): ADGRE5 mRNA
Genes: ADGRE5; CD97
Study 25527767 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1